Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicinal composition for curing hepatitis C

A pharmaceutical composition, hepatitis technology, applied in the direction of drug combination, pharmaceutical formula, active ingredients of hydroxyl compounds, etc., can solve problems such as side effects and drug resistance, and achieve the effect of fighting against hepatitis C and inhibiting virus replication

Active Publication Date: 2010-08-25
IND TECH RES INST
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these agents themselves have significant side effects, and most of them will develop drug resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for curing hepatitis C
  • Medicinal composition for curing hepatitis C
  • Medicinal composition for curing hepatitis C

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicinal composition for curing hepatitis C, which comprises 3,4,5-trihydroxy diphenylethylene oligomer serving as an active ingredient.

Description

technical field The invention relates to a pharmaceutical composition for treating hepatitis C, in particular to a 3,4,5-trihydroxystilbene oligomer for treating hepatitis C. Background technique According to the statistics of the World Health Organization (WHO), about 3% (about 300 million) of the world's population is infected with hepatitis C, which has become a worldwide public health problem. Most infected people do not show early symptoms and go undiagnosed. About 20% of people who are acutely infected recover by clearing the virus, but up to 80% develop chronic hepatitis, 20% of which lead to cirrhosis. Hepatitis C virus (HCV) is a positive single-stranded RNA virus, mainly transmitted through injection or contaminated blood preparations, resulting in hepatitis complex syndrome, including jaundice, loss of appetite, fatigue, abdominal pain, intermittent abnormal liver function, liver enzymes Abnormal rise in index, etc. Traditional and long-acting interferons and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/05A61K31/343A61K36/70A61K36/48A61K36/87A61K36/61A61P31/12A61P1/16A61K125/00
Inventor 李连滋饭沼宗和张秀凤殷韶禅伊藤哲朗
Owner IND TECH RES INST